請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58751
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 張祖亮(Tsu-Liang Chang) | |
dc.contributor.author | Kang-Ming Lo | en |
dc.contributor.author | 羅康銘 | zh_TW |
dc.date.accessioned | 2021-06-16T08:29:03Z | - |
dc.date.available | 2014-01-27 | |
dc.date.copyright | 2014-01-27 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2014-01-10 | |
dc.identifier.citation | 王子慶. 2000. 葡萄子與皮抗氧化性之研究. 屏東科技大學食品科學系碩士論文. 屏東.
宋細福. 1996. 舞菇之開發與研究(一). 行政院農業委員會農業試驗所技術服務. 1:14-17. 江千琦. 2005. 利用氣舉式發酵槽生產具有抑制肝癌及子宮頸癌細胞生長之樟芝發 酵液. 台灣大學食品科學研究所碩士論文. 臺北. 林秀卿. 1999. 食藥用菇類之呈味品質和抗氧化性質之評估.中興大學食品科學系 碩士論文. 臺中. 阮忠清、王銘詩. 2002. 生物化學(上). 及第出版社. 3:285-286. 呂欣怡. 2003. 舞菇多醣體成份之分析研究. 南台科技大學. 化學工程研究所碩士 論文. 臺南. 康名慰. 2002. 香菇菌種之胞外水溶性多醣體分析. 國立交通大學. 生物科技研究 所碩士論文. 新竹. 張為憲、李敏雄、呂政義、張永和、陳昭雄、孫璐西、陳怡宏、張基郁、嚴國欽、 林志城、林慶文. 1995. 食品化學. 國立編譯館. 華香出版社. 1:82-91. 黃仁彰. 2000. 菇類多醣體製劑的研究與應用. 財團法人食品工業發展研究所. 菌 種保存及研究簡訊. 黃鈴娟. 2000. 樟芝與姬松茸芝抗氧化性質及其多醣組成分析. 中興大學食品科學 系碩士論文. 臺中. 趙強. 1997. 對抗疾病與老化的新發現--自由基與抗氧化物質. 美食天下. 64:113-116 Adebayo, E.A., J.K. Oloke, and O.N. Majolagbe, R.A. Ajani and T.C. Bora. 2012. Antimicrobial and anti-inflammatory potential of polysaccharide from Pleurotus pulmonarius LAU 09, Afri. J. Microbiol. Res. 13: 3315-3323. Akinfemi, A., O.A. Adu and F. Doherty. 2010. Conversion of sorghum stover into animal feed with white-rot fungi Pleurotus ostreatus and Pleuoruts pulmonarius. Afri. J. Biotechnol. 11: 1706-1712. Akyuz, M., A.N. Onganer, P. Erecevit and S. Kirbag. 2010. Antimicrobial activity of some edible mushrooms in the eastern and southeast anatolia region of Turkey. GU J. Sci. 23: 125-130. Alam, N., K.N. Yoon and T.S. Lee. 2011. Antihyperlipidemic activities of Pleurotus ferulae on biochemical and histological function in hypercholesterolemic rats. J. Res. Med. Sci. 16: 776-786. Asfors, K.E. and K. Ley. 1993. Sulfated polysaccharides in inflammation. J. Lab. Clin. Med. 121: 201-202. Badole, S.L., N.M. Patel, P.A. Thakurdesai and S.L. Bodhankar. 2008. Interaction of aqueous Extract of Pleurotus pulmonarius Quel-Champ. with Glyburide in alloxan induced diabetic mice. Adv. Access Publication. 5: 159-164. Ballas, Z.K., W.L. Rasmussen and A.M. Krieg. 1996. Induction of N.K. activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157: 1840-1845. Bano, K., R.D. Kale and G.P. Satyavathi. 1993. Vermicompost as fertilizer for ornamental plants. I.V. National Symposium on Soil Biology and Ecology. p165-168. Bobek, P. and L. Ozdin. 1996. Oyster mushroom (Pleurotus ostreatus) reduces the production and secretion of very low density lipoproteins in hyper-cholesterolemic rats. J. Ernahrungswiss. 35: 249-252. Bobek, P., L. Kuniak and L. Ozdin. 1993. The mushroom Pleurotus ostreatus reduces secretion and accelerates the fractional turnover rate of very-low-density lipoproteins in the rat. Ann. Nutr. Metabol. 37: 142-145. Bobek, P., E. Ginter, and M. Jurcovicova, L. Ozdin and D. Mekinova. 1991. Cholesterol lowering effect of the mushroom Pleurotus ostreatus in hereditary hypercholesterolemic rats. Ann. Ntrl. Metabol. 35: 191-195. Bobek, P., L. Ozdin and L. Kuniak. 1997. Effect of Oyster mushroom and on the activities of antioxidative enzymes in rats fed the cholesterol diet. J. Ntrl. Biochem. 8: 469-471. Bobek, P., S. Galbavy and L. Ozdin. 1998. Effect of oyster mushroom (Pleurotus ostreatus) on pathological changes in dimethylhydrazine-induced rat colon cancer. Oncol. Rep. 5: 727-730. Brandt, C.R. and F. Piraino. 2000. Mushroom antivirals. Recent Res. Dev. Antimicrob. Agents Chemother. 4: 11-16. Buddi, R., B. Lin, S.R. Atilano, N.C. Zorapapel, M.C. Kenney and D.J. Brown. 2002. Evidence of oxidative stress in human comeal diseases. J. Histochem. Cytochem. 50: 341-51. Buswell, J.A. 2001. Fungal degradation of chlorinated monoaromatics and BTEX compounds. In: Fungi in Bioremediation, Ed. G.M. Gadd, Cambridge University Press, Cambridge. p113-135. Chang, S.T. and P.G. Miles. 1992. Mushroom biology a new discipline. Mycologist. 6: 64-65. Chang, S.T. 2006. The world mushroom industry: Trends and technological development. Int. J. Med. Mush. 8: 297-314. Chatterjee, S., G. Biswas, S.K. Basu and K. Acharya. 2011. Antineoplastic effect of mushrooms: a review. A. J. Crop Sci. 7: 904-911. Chen, J.N., E.G.D. Mejia and J.S.B. Wu. 2011. Inhibitory Effect of a Glycoprotein Isolated from Golden Oyster Mushroom (Pleurotus citrinopileatus) on the lipopolysaccharide -induced inflammatory Reaction in RAW 264.7 Macrophage. J. Agric. Food Chem. 59:7092-7097. Chen, J., D. Mao, Y. Yong, J. Li, H. Wei and L. Lu. 2012. Hepatoprotective and hypolipidemic effects of water-soluble polysaccharidic extract of Pleurotus eryngii. Food Chem. 130: 687-694. Chihara, G., Y. Maeda, J. Humora, T. Saski and F. Fukuoka. 1969. Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes. Nature. 222: 687-688. Chihara, G., J. Humora, Y. Maeda, Y. Arai and F. Fukuoka. 1970. Fractionation and purification of the polysaccharides with marked antitumor activity especially lentinan from lentinus edodes. Cancer Res. 30: 2776. Chihara G., Y. Meada, J. Taguchi, J. Hamuro. 1989. Lentinan as a host defence potentiator (HDP). Int. J. Immunotherapy. 5:145. Chihara, G. 1992. Immunopharmacology of Lentinan, a polysaccharide isolated from Lentinus edodes: its application as a host defence potentiator. Int. J. Oriental Med. 17:57-77. Choi, D.B., W.S. Cha, S.H. Kang and B.R. Lee. 2004. Effect of Pleurotus ferulae extracts on viability of human lung cancer and cervical cancer cell lines. Biotechnol. Bioprocess Eng. 9: 356-361. Cohen, R., L. Persky and Y. Hadar. 2002. Biotechnical applications and potential of wood-grading mushrooms of the genus Pleurotus. Appl. Microbiol. Biotechnol. 58: 582-594. Daba, A.S. 1998. Biochemical studies of effect of mushrooms and isolated polysaccharides on tumors transplanted in mice. 2nd Int. Conf. Daba, A.S., E. Wissa, A.Y. Esmat, M. Rashad, A. Fattah. 2002. Antitumor activity of polysaccharides from Pleurotus ostreatus fruiting bodies and mycelia cultivated on date waste media. Egyptian J. Biochem. Mol. Biol. Daba, A.S. and O.U. Ezeronye. 2003. Anti-cancer effect of polysaccharides isolated from higher basidiomycetes mushrooms. Afr. J. Biotech. 2: 672-678. Daba, A.S., G.A. Youssef, S.S. Kabeil and E.E. Hafez. 2011. Production of recombinant cellulase enzyme from Pleurotus ostreatus (Jacq.) P. Kumm. (type NRRL-0366). Afri. J. Microbiol. Res. 10: 1197-1202. Dalonso, N., R. Souza, M.L. Silveira, A.A. Ruzza, T.M. Wagner, E. and Wisbeck. 2010. Characterization and antineoplastic effect of extracts M. Soliman, obtained from Pleurotus sajor-caju fruiting bodies. Appl. Biochem. Biotechnol. 8: 2265-2274. El Bohi, K.M., L.L. Sabik, K.K. Muzandu, Z. Shaban, M. Soliman, M. Ishizuka et al. 2005. Antigenotoxic effect of Pleurotus cornucopiae extracts on the mutagenesis of Salmonella typhimurium TA98 elicited by benzo(a)pyrene and oxidative DNA lesions in V79 hamster lung cells. Jpn. J. Vet. Res. 52: 163-172. Espindola, L.H.S., F.S. Espindola, G.R.D. Freitas and M.A.M. Brandeburgo. 2007. Biodegradation of red 40 dye by the mushroom Pleurotus florida. Biosci. J. 23: 90-93. Filipic, M., A. Umek, A. Mlinaric. 2002. Screening of Basidiomycete mushroom extracts for antigenotoxic and bioantimutagenic activity. Pharmazie, 57: 416-20. Fu, H.Y., D.E. Shieh and C.T. Ho. 2009. Antioxidant and free radical scavenging activities of edible mushrooms. J. Food Lipids, 9: 35-43. Fugimoto, S., H. Furue. 1984. Clinical evaluation of Schizophyllan adjuvant immunochemotherapy for patients with resectable gastric cancer: a randomised control trial. Japanese J. Surgery 14:286-292. Fulleroton, S.A., A.A. Samadi. 2000. Induction of apoptosis in human prostate cancer cells with β-glucan (Maitake mushroom polysaccharides). Mol. Urology 4:7-13. Furne, H. 1985. Clinical evaluation of Schizophyllan (SPG) in gastric cancer-randomised control studies. Int. J. Immunopharmacol. 7:333-336. Furue, H., I. Kitoh. 1981. Phase 111-study on Lentinan. Japanese J. Cancer Chemotherapy 8:944-960. Gerasimenya, V.P., O.V. Efremenkova, O.V. Kamzolina, T.A. Bogush, I.V. Tolstych and V.A. Zennkova. 2002. Antimicrobial and antitoxical action of edible and medicinal mushroom Pleurotus ostreatus extracts. Intl. J. Med. Mush. 4: 127-132. Gibbs, W.W. 2003. Untangling the root of cancer. Sci. Am. 289:48-57. Gorin, P.A.J., and E. Berger. 1983. The chemistry of polysaccharides of fungi and lichens. In Asp. G.O. 2:365-409 Gregori, A., M. Svagelj and J. Pohleven. 2007. Cultivation techniques and medicinal properties of Pleurotus spp. Food Technol. Biotech. 45: 238-249. Gregory, F.J. 1966. Studies on antitumor substances produced by basidiomycetes. Mycologia 58:80-90. Gu, Y.H. and G. Sivam. 2006. Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen independent prostate cancer PC-3 cells. J. Med. Food, 9: 196-204. Gunde-Cimerman, N. and A. Plemenitas. 2001. Hyporcholesterolemic activity of the genus Pleurotus (Jacq.: Fr.) P. Kumm. (Agaricales s. l. Basidiomycetes). Intl. J. Med. Mush. 3: 395-397. Hagiwara, S.Y., M. Takahashi, Y. Shen, S. Kaihou, T. Tomiyama, M. Yazawa, Y. Tamai and M. Terazawa. 2005. A phytochemical in the edible Tamogi-take mushroom (Pleurotus cornucopiae), D-Mannitol, inhibits ACE activity and lowers the blood pressure of spontaneously hypertensive rats. Bioscience, Biotech. Biochem. 8: 1603-1605. Hasler, C.M. 1996. Functional food: the western prospective. Nutrit. Rev. 54: 506-510. Hawksworth, D.L. 2001. Mushrooms: the extent of the unexplored potential. Int. J. Med. Mush. 3: 333-340. Hobbs, C. 2000. Medicinal value of Lentinus edodes (berk) sing (agricomycetideae): a literature review. Int. J. Med. Muschroom 2:287-302. Hossain, S., M. Hashimoto, E.K. Choudhury, N. Alam, S. Hussain, M. Hasan, S.K. Choudhury and I. Mahmud. 2003. Dietary mushroom (Pleurotus ostreatus) ameliorates atherogenic lipid in hyper-cholesterolaemic rats. Clinical and experimental pharmacol. Physiol. 30: 470-475. Ikekawa, T., M. Nakanishi, N. Uehara, G. Chihara and F. Fukuoka. 1968. Antitumor action of some Basidiomycetes, especially Phellinus linteus. Jpn. J. Cancer Res. 59:155-157. Iwalokun, B.A., U.A. Usen, A.A. Otunba and D.K. Olukoya. 2007. Comparative phytochemical evaluation, antimicrobial and antioxidant properties of Pleurotus ostreatus. Afri. J. Biotechnol. 6: 1732-1739. Jang, M., L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W.W Beecher, H.H.S. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto. 1997. Cancer chemopreventive ctivity of resveratrol, a natural product derived from grapes. Sci. 10:218-221. Jayakumar, T., P.A. Thomas and P. Geraldine. 2007. Protective effect of an extract of the oyster mushroom, Pleurotus ostreatus, on antioxidants of major organs of aged rats. Exp. Gerontol. 42: 183-191. Jedinak, A., S. Dudhgaonkar, Q.L. Wu, J. Simon and D. Sliva. 2011. Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-kB and AP-1 signaling. Nutri. J. 10: 52-62. Jones, K. 1998. Maitake a patent medicinal food. Alternative complementary therapy. 12:420-429. Jose, N., T.A. Ajith and K.K. Jananrdhanan. 2002. Antioxidant, antiinflammatory and antitumor activities of culinary-medicinal mushroom Pleurotus pulmonarius (Fr.) Quel. (Agaricomycetideae). Int. J. Med. Mush. 4: 329-335. Kamiyama, Y. 1992. Improving effect of active hexose correlated compound on the prognosis of postoperative hepatocellular carcinoma patients. Eur. J. Surgical Res. 31:216-217. Kaul, T.N. 1997. Introduction to mushroom science: medicine reviews. Enf. Sci. Inc. 5:4-27 Keyhani, J., E. Keyhani and L. Arzi. 2007. Anti-oxidative stress enzymes in Pleurotus ostreatus. Acta Hort. 739: 420-427. Khan, M.A. and M. Tania. 2012. Nutritional and medicinal importance of Pleurotus mushroom: An overview. Food Review Int. 3: 313-329. King, T.A. 1993. Mushrooms, the ultimate health food but little research in U.S to prove it. Mush. News, 41: 29-46. Kirk, P.M., P.F. Cannon, D.W. Minter and J.A. Stalpers. 2008. Dictionary of the fungi (10 ed.), the CABI, Wallingford, UK. Kim, J.H., S.J. Kim, H.R. Park, J.I. Choi, Y.C. Ju, K.C. Nam, S.J. Kim and S.C. Lee, 2009. The different antioxidant and anticancer activities depending on the color of oyster mushrooms. J. Med. Plants Res. 3: 1016-1020. Kim, M.Y., M.H. Park, G.H. Kim. 1997. Effects of mushroom protein-bound polysaccharides on the blood glucose levels and energy metabolism in streptozotocin-induced diabetic rats. J. Kor. Nutr. 30: 743-750. Kimura, Y., H. Mizuno, K. Satake, H. Tahara, M. Tsukuda. 1994. Clinical evaluation of sizofiran an assistant immunotherapy in treatment of head and neck cancer. Acta. Otolargynzol. 511:192-195. Kurashiga, S., Y. Akuzawa, and F. Eudo. 1997. Effect of Lentinus edodes, Grifola Frondosa and Pleurotus ostreatus administration on cancer outbreak and activities of macrophages and lymphocytes in mice treated with a carcinogen. Immunopharmacol. Immunotoxicol. 19:175-185. Kurashige, S., Y. Akuzawa and F. Endo. 1997. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol. Immunotoxicol. 19: 175-83. Lakshmi, B., N. Jose, T.A. Ajith and K.K. Jananrdhanan. 2004. Antimutagenic activity of methanolic extract of culinary-medicinal oyster mushroom, Pleurotus ostreatus (Jacq.: Fr.) Kumm. (strain floric Eger nom. Nud.) and its protective effect against benzo(a) pyrene-induced hepatic damages. Int. J. Med. Mush. 6: 139-149. Lee, E.W., P. He, H. Kawagishi and K. Sugiyama. 2000. Suppression of D-galactosamine induced liver injury by mushroom in rats. Biosci. Biotech.Biochem. 64: 2001-2004. Li, Y.R., Q.H. Liu, H.X. Wang and T.B. Ng. 2008. A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus. Biochimica et Biophysica Acta (BBA) GeneralSubjects, 1780: 51-57. Li, L., T.B. Ng, M. Song, F. Yuan, Z.K. Liu, C.L. Wang, Y. Jiang, M. Fu and F. Liu, 2007. A polysaccharide-peptide complex from abalone mushroom (Pleurotus abalonus) fruiting bodies increases activities and gene expression of antioxidant enzymes and reduces lipid peroxidation in senescence-accelerated mice, Appl. Microbiol. Biotechnol. 75: 863-869. Lindequist, U., T.H.J. Niedermeyer and W.D. Julich. 2005. The pharmacological potential of mushrooms: Evidence based complement. Altern. Med. 2: 285-299. Lo, S.H. 2005. Quality evaluation of Agaricus bisporus, Pleurotus eryngii, Pleurotus ferulae, Pleurotus ostreatus and their antioxidant properties during post-harvest storage, Master’s thesis, National Chung-Hsing University, Taichung, Taiwan. Lucas, E.H., R. Montesano, M.S. Pepper, M. Hafner, and E.Sablon. 1957. Tumor inhibitors in Boletus edulis and other holobasidiomycetes. Antibiotics Chem. 7:1-4. Lv, H., Y. Kong, Q. Yao, B. Zhang, F.W. Leng, H.J. Bian, J. Balzarini, E.V. Damme and J.K. Bao. 2009. Nebrodeolysin, a novel haemolytic protein from mushroom Pleurotus nebrodensis with apoptosis-inducing and anti-HIV-1 effects. Phytomedicine. 16:198-205. Maede, Y.Y., J. Hamuro, and G. Chihara. 1971. The mechanism of action of antitumor polysaccharides: The effect of anti-lymphocyte serum on the antitumor activity of lentinan. Int. J. Cancer 8:40-41. Maede, Y.Y., J. Hamuro, and G. Chihara. 1974. The nature of immunopotentiation by the antitumor polysaccharide lentinan and the significance of biogenic amines in its action. Int. J. Cancer 12:259-281. Maede, Y.Y., M. Sakaizumi, K. Moriwaki, and H. Yonekawa. 1991. Genetic control of the expression of two biological activities of an antitumor polysaccharide, lentinan. Int. J. unopharmacol. 13:977. Maede, Y.Y., H. Yonekawa, and G. Chihara. 1994. Application of lentinan as cytokine and host defence in immunotherapy of infectious disease. In:Immunotherapy of Infections. Ed. K.N.Misha. pp. 1:261-279. Maiti, S., S.K. Mallick, S.K. Bhutia, B. Behera, M. Mandal and T.K. Maiti. 2011. Antitumor effect of culinary-medicinal oyster mushroom, Pleurotus ostreatus P. Kumm. derived protein fraction on tumor-bearing mice models. Intl. J. Med. Mush. 13: 427-40. Masaphy, S., Y. Henis and D. Levanon. 1996. Manganese-Enhanced Biotransformation of Atrazine by the White Rot Fungus Pleurotus pulmonarius and Its Correlation with Oxidation Activity. Appl. Environ. Microbiol. 62: 3587-3593. Mau, J.L., H.C. Lin and S.F. Song. 2002. Antioxidant properties of several specialty mushrooms. Food Res. Int. 35: 519-526. Mau, J.L., G.R. Chao and K.T. Wu. 2001. Antioxidant properties of methanolic extracts from several ear mushrooms. J. Agric. Food Chem. 49: 5461-5467. Meng, G.L. and F.L. Li. 1997. Fungal toxin and their application value. J. Biol. 14: 28-29. Miyazaki, K., H. Mizutani, H. Katabuchi, K. Fukuma, S. Fujsaki, and H. Okamura. 1995. Activated T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell mediated immunity and survival. Gynecol. Oncol. 56:412-420. Miyazawa, N., M. Okazaki and S. Ohga. 2008. Antihypertensive effect of Pleurotus nebrodensis in spontaneously hypertensive rats. L. Oleo Sci. 57: 675-681. Miyazawa, N., F. Eguchi, Y. Kitazima, Y. Kitamoto. 2003. Proceeding of Japanese Society of Mushroom Science and Biotechnology Congress, Gumma. Mizuno, T., P. Yeohlui, T. Kinoshita, C. Zhuang, H. Ito, and Y. Mayuzumi. 1996. Antitumor activity and chemical modification of polysaccharides from niohshimeji mushroom, tricholoma anteum. Biosci. Biotechnol. Biochem. 60:30-33. Mizuno, T. 1995. Bioactive biomolecules of mushrooms: food functions and medicinal effects of mushroom fungi. Food Rev. Int. 11:7-21. Mizuno, T. 1999. The extraction and development of antitumor active polysaccharides from medicinal mushrooms in Japan. Int. Med. 1:9-30. Morgan, P., S.T. Lewis and R.J. Watkinson. 1991. Comparison of abilities of white-rot fungi to mineralize selected xenobiotic compounds. Appl. Environ. Microbiol. 34: 693-696. Morschhauser, J., G. Kohler, W. Ziebuhr, G. Blum-Oehler, U. Dobrindt and J. Hacker. 2000. Evolution of microbial pathogens. Phil. Trans. R. Soc. Lond. B. 355: 695-704. Nanba, H. 1993. Maitake mushroom-the king mushroom. Mush. News. 41: 22-25 Nanba, H. 1997. Effect of maitake d-fraction on cancer prevention. Ann. New York Acad. Sci. 833:204-207. Nanba, H. 1997. Maitake d-fraction: healing and preventive potential for cancer. J. Orthomolecular Med. 12:43-49. Naraian, R., D. Singh, A. Verma and S.K. Garg. 2010. Studies on in vitro degradability of mixed crude enzyme extracts produced from Pleurotus spp.J.Environ. Biol. 31: 945-951. Nikolova, D., G. Bjelakovic, L.L. Gluud, R.G. Simonetti and C. Gluud. 2007. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. J. American Medi. Assoc. 297:842-857. Nithya, R. and R. Ragunathan. 2009. Synthesis of silver nanoparticle using Pleurotus Sajor-caju and its antimicrobial study. Digest J. Nanomaterials and Biostructures. 4:623-629. Nishida, I., H. Nanba, and H. Kuroda. 1988. Antitumor activity exhibited by orally administered extracts from fruit body of Grifola frondosa. Chem. Pharm. Bull. 36:1819-1827. Nosalova, V., P. Bobek, S. Cerna, S. Galbavy and S. Stvrtina. 2001. Effects of pleuran ($-glucanisolated from Pleurotus ostreatus) on experimental colitis in rats. Physiol. Res. 50:575-581. Nozaki, H., S. Itonori, M. Sugita, K. Nakamura, K. Ohba, A. Suzuki and Y. Kushi, 2008. Mushroom acidic glycosphingolipid induction of cytokine secretion from murine T cells and proliferation of NK1.1 alpha/beta TCR-double positive cells in vitro. Biochem. Biophys. Res. Commun. 373:35-439. Okamura, K., T. Kinukawa, Y. Tsumura, T. Otani, T. Itoh, H. Kobayashi, O. Matsuura, M. Kobayashi, T. Fukutsu, and S. Ohshima. 1986. Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer: a randomized controlled study. Cancer. 58:865-872. Okamura, K., T. Kinukawa, Y. Tsumura, T. Otani, T. Itoh, H. Kobayashi, O. Matsuura, M. Kobayashi, T. Fukutsu, and S. Ohshima. 1989. Adjuvant immunochemotherapy: two randomized controlled studies of patients with cervical cancer. Biomed. Phar. 43:13-17. Ooi, V.E.C., and F. Liu. 1999. A review of pharmacological activities of mushroom polysaccharides. Int. J. Med. 1:195-206. Ooi, V.E.C. and F. Liu. 2000. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes, Curr. Med. Chem. 7: 715-729. Piraino, F. and C.R. Brandt. 1999. Isolation and partial characterization of an antiviral, RC-183, from the edible mushroom Rozites caperata. Antiviral Res. 43: 67-78. Rai, R.D. 2007. Medicinal Mushroom. In: Advances in Mushroom Biology and Production, Eds. R.D. Rai, B.L. Dhar, R.N. Verma, Mushroom Society of India, National Research Centre for Mushroom, Solan-India. 12:355-368. Ramkumar, L., T. Ramanathan, P. Thirunavukkarasu and N. Arivuselvan. 2010. Antioxidant and radical scavenging activity of nine edible mushrooms extract. Intl. J. Pharmacol. 6:950-953. Rajarathnam, S. and Z. Bano. 1989. Pleurotus mushroom part III. Biotransformation of natural lignocellulosic wastes: commercial applications and implications. Crit. Reviews in Food Sci. Nutri. 28:31-113. Rajarathanam, S., M.N. Sashirekha and Z. Bano. 1992. Biopotentialities of basidiomycetes. Adv. Appl. Microbiol. 37:233-361. Rajewska, J. and B. Balasinska. 2004. Biologically active compounds of edible mushrooms and their beneficial impact on health. Postepy. Hig. Med. Dosw. 58: 352-357. Reddy, C.A. and Z. Mathew. 2001. Bioremediation potential of white rot fungi. In: Fungi in bioremediation, Ed. G.M. Gadd, Cambridge University Press, London. 6:52-78. Refaie, F.M., A.Y. Esmat, A.S. Daba and S.M. Taha. 2009. Characterization of polysaccharopeptides from Pleurotus ostreatus mycelium: assessment of toxicity and immunomodulation in vivo. Micol. Appl. Int. 21:67-75. Refaie, F.M., A.Y. Esmat, A.S. Daba, W.M. Osman and S.M. Taha. 2010. Hepatoprotective activity of polysaccharo-peptidesfrom Pleurotus ostreatus mycelium on thioacetamidein toxicated mice. Micologia Aplicada Intl. 22: 1-13. Ross, G.D., V. Vetvicka, J. Yan, Y. Xia, and J. Vetvickova. 1999. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology. 42:61-74. Sachin, L.B., N.S. Shweta, M.P. Naimesh, A.T. Prasad and L.B. Subhash. 2006. Hypoglycemic Activity of Aqueous Extract of Pleurotus pulmonarius in Alloxan-Induced Diabetic Mice. Pharmaceuti. Biol. 44:421-425. Sadler, M. and M. Saltmarsh. 1998. Functional foods: The consumer, the products and the evidence. Royal Soc. Chem. Cambridge. Sagakami, H., T. Aohi, A. Simpson and S. Tanuma. 1991. Induction of immunopotentiation activity by a protein-bound polysaccharide PSK. Anticancer Res. 11: 993-1,000. Saha, A.K., S. Acharya and A. Roy. 2012. Antioxidant level of wild edible mushroom: Pleurotus djamor (Fr.) Boedijn. J. Agric. Technol. 8:1343-1351. Salmones, D., G. Mata, K.N. Waliszewski. 2005. Comparative culturing of Pleurotus spp. on coffee pulp and wheat straw: biomass production and substrate biodegradation. Bioresourse Technol. 96:537-544. Sandven, P. 2000. Epidemiology of canidemia. Rev. Iberoam Micol. 17: 73-81. Sano, M., K. Yoshino, T. Matsuzawa and T. Ikekawa. 2002. Inhibitory effects of edible higher basidiomycetes mushroom extracts on mouse type IV allergy. Int. J. Med. Mush. 4:37-41. Sarangi, I., D. Ghosh, S.K. Bhutia, S.K. Mallick and T.K. Maiti. 2006. Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia derived proteoglycans. Intl. Immunopharmacol. 6:1287-1297. Selegean, M., M.V. Putz and T. Rugea. 2009. Effect of the Polysaccharide Extract from the Edible Mushroom Pleurotus ostreatus against Infectious Bursal Disease Virus. Intl. J. Mol. Sci. 10:3616-3634. Selvi, S., S. Arunavadas and P. Umadevi. 2008. Hepatoprotective effect of the ethanolic extract of Pleurotus florida and Calocybe indica against CCL4 induced hepatic damage in albino rats. The Icfai Univ. J. Life Sci. 2: 17-28. Sharma, S.G., M. Fatma and V.K. Singh. 1996. Biochemical changes during solid substrate fermentation of water hyacinth with Pleurotus sajor-caju. Mush. Res. 5: 89-91. Sharon, N., and H. Lis. 1993. Carbohydrates in cell recognition. Sci. Am. 1:74-81. Shashoua, V.E. and D.S. Adams. 2004. New synthetic peptides can enhance gene expression of key antioxidant defence enzymes in vitro and in vivo. Brain Res. 1024:34-43. Shi, Y.L., A.E. James, I.F. Benzie and J.A. Buswell. 2002. Mushroom derived preparations in the prevention of H2O2-induced oxidative damage to cellular DNA. Teratog Carcinog Mutagen. 22:103-111. Shin, K.S., I.K. Oh and C.J. Kim. 1997. Production and purification of Remazol Brilliant Blue R decolorizing peroxidase from the culture filtrate of Pleurotus. Appl. Environ. Microbiol. 63: 1744-1748. Shlyakhovenko, V.A., S.V. Olishevsky, V.V. Kozak, Y.V. Yanish and S.L. Rybalko. 2003. Anticancer and immunostimulatory effects of nucleoprotein fraction of Bacillus subtilis 7025 culture medium filtrate. Exp. Oncol. 25: 119-23. Singh, C.S., R. Sharma, Y. Patel and V.K. Singh. 2010. Management of agricultural solid wastes by locally isolated Pleurotus species, a white rot fungi. Asian J. Microbiol. Biotech. Env. Sci. 13: 561-564. Smith, J.E., N.J. Rowan and R. Sullivan. 2002. Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities, Biotechnol. Lett. 24: 1839-45. Suga, T., Y.Y. Meada, H. Uchida, M. Rokutanda, and G. Chihara. 1986. Macrophage mediated acute phase transport protein production induced by lentinan. Int. J. Immunopharmacol. 8:690-691. Sumy, A.K., N. Jahan, N. Sultana and S.M. Ruhul-Amin. 2011. Effect of oyster mushroom (Pleurotus florida) on paracetamol induced changes of serum bilirubin level and liver tissue protein in Rats. J. Bangladesh Soc. Physiol. 6:10-15. Sun, S., C. Beard, R. Jaenisch, P. Jones and J. Sprent. 1997. Mitogenecity of DNA from different organisms for murine B cells. J. Immunol. 159: 3119-3125. Svrcek, P.S., J. Mojzisova, A. Durove, Z. Benisek and M. Huska. 1996. The immunomodulatory effect of the soluble fungal glucan (Pleurotus ostreatus) on delayed hypersensitivity and phagocytic ability of blood leucocytes in mice. Zentralbl Veterinarmed B. 43:129-135. Taira, K., Y. Miyashita, K. Okamoto, S. Arimoto, E. Takahashi and T. Negishi. 2005. Novel antimutagenic factors derived from the edible mushroom Agrocybe cylindracea. Mutation Res. 586:115-123. Tam, S.C., K.P. Yip, K.P. Fund and S.T. Chang. 1986. Hypotensive and renal effect of an extract of the edible mushroom Pleurotus sajor-caju. Life Sci. 38:1155. Thomson, K.S. and E.S. Moland. 2000. The new blactamases of Gram-negative bacteria at the dawn of the new millennium. Microbes and Infection. 2:1225-1235. Tzianabos, A. 2000. Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function. Clin. Microbiol. Rev. 13: 523-533. Venkatakrishnana, V., R. Shenbhagaramanb, V. Kaviyarasanb, D. Gunasundaric, K. Radhikad, R. Dandapania, Loganathan and K. Jagadishb. 2010. Antioxidant and Antiproliferative Effect of Pleurotus ostreatus. J. Phytol. 2:22-28. Wang, H.X. and T.B. Ng. 2004. Purification of a novel low-molecular-mass laccase with HIV-1 reverse transcriptase inhibitor activity from the mushroom Tricholoma giganteum. Biochem. Biophys. Res. Commun. 315:450-454. Wang, H.X. and T.B. Ng. 2000. Quinqueginsin, a novel protein with anti-human immunodeficiency virus, antifungal, ribonuclease and cell-free translation inhibitor activities from American ginseng roots. Biochem. Biophys. Res. Commun. 269:155-159. Wang, H.X. and T.B. Ng. 2001. Isolation of Pleuturegin, a novel ribosome-inactivating protein from fresh sclerotia of the edible mushroom Pleurotus tuber-regium. Biochem. Biophysical Res. Commun. 288:718-721. Wang, H.X., T.B. Ng and V.E.C. Ooi. 1998. Biochem. Biophys. Res. Commun. 250: 544-546. Wang, J., X.H. Wang and T.B. Ng. 2007. A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa. Peptides, 28: 560-565. Wasser, S.P. and A.L. Weis. 1999. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: Current perspectives (Review). Int. J. Med. Mush. 1:31-62. Wasser, S.P. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides (minireview). Appl. Microbiol. Biotechnol. 60:258-274. Watanabe, T. 1969. Antineoplastic activity of polysaccharides of Pleurotus ostreatus. Nippon Rinsho. 27:1759-1761. Wolff, E.R., S.E. Wisbeck, M.L.L. Silveira, R.M.M Gern, M.S.L. Pinho and S.A. Furlan. 2008. Antimicrobial and antineoplasic activity of Pleurotus ostreatus. Appl. Biochem. Biotechnol. 151:402-412. Yoon, K.N., N. Alam, M.J. Shim and T.S. Lee. 2012. Hypolipidemic and antiatherogenesis effect of culinary-medicinal pink oyster mushroom, Pleurotus djamor L. Vass. (higher Basidiomycetes), in hypercholesterolemic rats. Int. J. Med. Mush. 14:27-36. Yuan, Z.M., P.M. He, J.H. Cui and H. Takeuchi. 1998. Hypoglycemic effect of water-soluble polysaccharide from Auricularia auricula-judae Quel. of genetic diabetic KK-Ay mice. Biosci. Biotechnol. Biochem. 62:1898-1903. Zadrazil F. 1978. Cultivation of Pleurotus. In: The Biology and Cultivation of edible mushrooms, Eds. S.T. Chang and W.A. Hayes, Academic Press, USA. 61: 521-557. Zhang, F., H. Ning and M. Zhang. 2004. Toxins in toadstools and the exploitation and utilization of toadstools. J. Yunnan Agric. Univ. 19:284-286. Zhang, J., G. Wang, H. Li, C. Zhuang, T. Mizuno, H. Ito, H. Mayuzumi, H. Okamoto and J. Li. 1994. Antitumor polysaccharides from Chinese mushroom,“ Yuhuahgmo”, the fruiting body of Pleurotus citrinopileatus. Biosci. Biotechnol. Biochem. 58:1195-1201. Zhuang, C., T. Mizuno, A. Shimada, H. Ito, C. Suzuki and Y. Mayuzumi. 1993. Antitumor protein-containing polysaccharides from a Chinese mushroom Fengweiguor Houbitake, Pleurotus sajor-caju (Fr.) Sings.Biosci. Biotechnol. Biochem. 57:901-906. Zusman, I., R. Reifen, O. Livni, P. Smirnoff, P. Gurevich, B. Sandler, A. Nyvska, R. Gal, Y. Tendler and Z. Madar. 1997. Role of apoptosis, proliferating cell nuclear antigen and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatus. Anticancer Res. 17:2105-2113. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58751 | - |
dc.description.abstract | 蕈類不僅可當作食物,它獨特的內含物在醫學上更是一種極具有價值的成分,這些內含物包含許多蕈類的二級代謝物,例如酚類化合物、多肽化合物、萜類物質、類固醇、外源凝集素、多醣體、多醣體生肽和多醣蛋白複合物。蕈類含有豐富的多醣體,近年來的研究將多醣體利用於許多生物試驗上,例如糖尿病、降低膽固醇、抗老化、抑制惡性腫瘤等等。粉紅菇(Pleurotus djamor)是一種在市場上新興的蕈類,屬於蠔菇類(oyster mushroom)的側耳菇,其多醣體的含量和生物活性目前還未被完整的發現,但從前人文獻中發現蠔菇類之熱水及醇類萃取物具有抗菌作用、抗病毒作用、抗人類後天免疫缺陷病毒、抗肉瘤作用、抗誘變作用、抗低血壓作用、保肝作用、降膽固醇作用、抗腫瘤作用、抗氧化作用、降血糖作用、抗發炎反應、免疫調節、抗老化作用等等多種生物活性潛力。本試驗特別針對粉紅菇熱水萃取物之多醣體進行試驗,分別測定了粉紅菇多醣體萃取物之還原能力、清除DPPH能力及清除H2O2之能力等等多種抗氧化力性質,也同時測定了粉紅菇多醣體萃取物之總醣量、分子量分布。粉紅菇多醣體萃取物之對於生物活性之試驗,探討生物活性的方式是透過子宮頸癌細胞(Hela)的MTT細胞存活率試驗來觀察粉紅菇的生物活性並觀察粉紅菇多醣體對於人類肝癌細胞株(HA22T)、人類乳癌細胞株(MCF7)、子宮頸癌細胞株的形態是否發生改變。 | zh_TW |
dc.description.abstract | Mushrooms have been not only used as food materials with their unique flavor and texture, but also recognized as an important source of biologically active compound of medicinal value. Mushrooms have a variety of accumulated secondary metabolites such as phenolic compounds, polypeptides, terpenes, and steroids. Mushrooms also have lectins, polysaccharides, polysaccharide-peptides, and polysaccharide-protein complexes which are known to have immunomodulatory and anticancer activities. Mushroom is rich in polysaccharides, and the polysaccharides has been recently researched for many biological and medical tests, such as treating diabetes, lowering the cholesterol, anti-aging, cancer-inhibiting and so on. Pink oyster mushroom (Pleurotus djamor) is a kind of mushrooms emerging on the market, and it is one of the oyster mushroom in Pleurotus. Its polysaccharide content and the biological activity has yet to be fully discovered, so that this test through the MTT cell viability test by the cervix cancer cells (Hela) to observe the biological activity of pink oyster mushroom and also we observe the morphology change of different cancer cell lines through adding the polysaccharides. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T08:29:03Z (GMT). No. of bitstreams: 1 ntu-102-R00628121-1.pdf: 2043102 bytes, checksum: 04c59230927fd0f488bb95b717603fee (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 口試委員審定書...............................................................................................................#
謝誌....................................................................................................................................i 中文摘要...........................................................................................................................ii ABSTRACT.....................................................................................................................iii CONTENTS.....................................................................................................................iv 圖目錄...........................................................................................................................viii 表目錄.............................................................................................................................ix Chapter 1 簡介................................................................................................................1 Chapter 2 文獻回顧........................................................................................................3 2.1抗菌作用(Antimicrobial).....................................................................................3 2.2抗病毒作用(Antiviral).........................................................................................3 2.3抗人類免疫缺陷病毒(Anti-Human Immunodeficiency Virus, HIV).................4 2.4抗肉瘤作用(Antineoplasticism)..........................................................................4 2.5抗腫瘤作用(Antitumor)......................................................................................5 2.6抗誘變作用(Antimutagenesis)............................................................................5 2.7抗氧化作用(Antioxidation).................................................................................6 2.7.1自氧化反應...............................................................................................7 2.7.1.1自氧化反應機構....................................................................................8 2.7.1.2抗氧化劑................................................................................................9 2.7.1.3抗氧化物................................................................................................9 2.7.2自由基致癌、促癌作用及其發生機制...................................................10 2.7.2.1自由基在化學致癌過程中的作用..............................................10 2.7.2.2自由基與促癌作用......................................................................11 2.7.2.3自由基致癌和促癌可能發生的機制..........................................13 2.8降血脂作用(Antilipidemia)...............................................................................15 2.9降血糖作用(Anti-Hyperglycemia)....................................................................15 2.10抗低血壓作用(Anti-Hypotension)..................................................................16 2.11抗發炎反應(Anti-Inflammation).....................................................................16 2.12保肝作用(Hepatoprotection)...........................................................................17 2.13降膽固醇作用(Hypocholesterolemia).............................................................17 2.14免疫調節(Immunomodulatory).......................................................................18 2.15抗老化作用(Anti-Ageing)...............................................................................18 Chapter 3 材料與方法..................................................................................................19 3.1材料與藥品........................................................................................................19 3.1.1粉紅菇菌種.............................................................................................19 3.1.2藥品.........................................................................................................19 3.1.3實驗儀器.................................................................................................21 3.2 粉紅菇多醣體萃取..........................................................................................22 3.2.1一次純化粗多醣.....................................................................................23 3.2.2二次純化粗多醣.....................................................................................24 3.2.3去除帶電分子.........................................................................................24 3.2.4去除聚醣蛋白複合體.............................................................................24 3.2.5去除蛋白質.............................................................................................24 3.3總醣測定............................................................................................................25 3.4分子量測定........................................................................................................26 3.5抗氧化性質分析................................................................................................26 3.5.1還原能力測定.........................................................................................27 3.5.2清除DPPH自由基能力測定..................................................................27 3.5.3清除 H2O2的測定..................................................................................28 3.6解凍冷凍細胞....................................................................................................28 3.7細胞繼代培養....................................................................................................30 3.8細胞計數............................................................................................................31 3.9細胞冷凍保存....................................................................................................32 3.10 細胞實驗操作................................................................................................33 3.11磷酸鹽緩衝溶液配製......................................................................................34 3.12 胎牛血清配製................................................................................................34 3.13 培養基配製....................................................................................................35 3.14 MTT assay 細胞存活率分析.........................................................................35 3.15細胞免疫螢光染色..........................................................................................36 Chapter 4 結果與討論..................................................................................................38 4.1 總醣含量分析..................................................................................................38 4.2 分子量之測定..................................................................................................40 4.3 粉紅菇抗氧化性質分析..................................................................................43 4.3.1 還原能力測定.......................................................................................43 4.3.2 清除DPPH自由基能力測定................................................................49 4.3.3 清除H2O2能力測定..............................................................................53 4.4 多醣抑制腫瘤細胞分析..................................................................................59 Chapter 5 結論..............................................................................................................66 Chapter 6 參考文獻......................................................................................................68 | |
dc.language.iso | zh-TW | |
dc.title | 粉紅菇多醣體之生物活性 | zh_TW |
dc.title | Biological Activity of Polysaccharides of Pleurotus djamor Extracts | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳開憲,林佼穎 | |
dc.subject.keyword | 粉紅菇,多醣體,生物活性, | zh_TW |
dc.subject.keyword | Pleurotus djamor,polysaccharide,biological activity, | en |
dc.relation.page | 87 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-01-10 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 園藝學研究所 | zh_TW |
顯示於系所單位: | 園藝暨景觀學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 2 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。